Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 6—June 2022

Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016

Sarah A. HookComments to Author , Seonghye Jeon, Sara A. Niesobecki, AmberJean P. Hansen, James I. Meek, Jenna K.H. Bjork, Franny M. Dorr, Heather J. Rutz, Katherine A. Feldman, Jennifer L. White, P. Bryon Backenson, Manjunath B. Shankar, Martin I. Meltzer, and Alison F. Hinckley
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (S.A. Hook, A.F. Hinckley); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Jeon, M.B. Shankar, M.I. Meltzer); Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA (S.A. Niesobecki, A.P. Hansen, J.I. Meek); Minnesota Department of Health, St. Paul, Minnesota, USA (J.K.H. Bjork, F.M. Dorr); Maryland Department of Health, Baltimore, Maryland, USA (H.J. Rutz, K.A. Feldman); New York State Department of Health, Albany, New York, USA (J.L. White, P.B. Backenson)

Main Article

Table 3

Patient perspective of cost of Lyme disease per participant, by disease category, in high-incidence areas, United States, 2014–2016

Disease category
No. participants
Patient perspective, cost per participant,* 2016 US dollars
10th percentile
90th percentile
All† 901 244 1,252 2,972 29 3,139 0–30,628
Confirmed localized 402 170 1,070 4,164 27 2,535 1–26,686
Confirmed disseminated 238 358 1,692 7,323 32 4,116 2–30,628
Probable 261 315 1,277 4,629 34 3,987 0–18,833

*Cost per participant according to the patient perspective represents the sum of patient medical costs, nonmedical costs, cost of productivity losses, and other related costs as reported by each participant on all surveys. †Estimates for the overall population use the sample-weighted data except the range.

Main Article

Page created: April 03, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.